RCT1213 / ReCerise Therapeutics - LARVOL DELTA

ADDING MULTIMEDIA ReCerise Signs New Research Collaboration Agreement towards Development of Innovative Treatment for Hepatocellular Carcinoma (Businesswire) - "ReCerise Therapeutics Inc...recently entered a research partnership with the National Cancer Centre Singapore ('NCCS') to develop innovative treatments utilizing multi-omics data analyses in hepatocellular carcinoma (HCC)...This collaboration will be conducted under the PLANet programme...'Through this joint research, we plan to conduct multi-faceted studies on the development potential of RCT1213, a hepatocellular carcinoma treatment candidate currently under development, by utilizing the various omics data and research database of Asian HCC patients at NCCS.' The research collaboration between these two parties is a research and development project funded by the Korean government and is subject to the management and supervision of the Korea Evaluation Institute of Industrial Technology (KEIT)."

Commercial • Hepatocellular Cancer